Revolution Medicines holder plans sale of 75,894 shares

Revolution Medicines, Inc. (RVMD) received a notice under Rule 144 that Jeffrey Todd Cislini plans to sell restricted common stock through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) received a notice under Rule 144 that Jeffrey Todd Cislini plans to sell restricted common stock through Morgan Stanley Smith Barney LLC. The notice covers up to 75,894 shares of common stock, with an aggregate market value of $16,069,416.09, on or after August 21, 2026 on the NASDAQ.

The securities to be sold include shares underlying restricted stock units and shares issuable upon the exercise of stock options from the issuer. RVMD had 214,336,418 shares outstanding at the time referenced. Cislini also reports having sold 2,157 shares for $336,748.90 during the prior three months.

Key Figures

Shares to be sold: 75,894 shares of common stock Aggregate market value of planned sale: $16,069,416.09 Shares outstanding: 214,336,418 shares +4 more

7 metrics

Shares to be sold 75,894 shares of common stock Planned sale under Rule 144 through broker Morgan Stanley Smith Barney LLC

Aggregate market value of planned sale $16,069,416.09 Market value of the 75,894 RVMD shares covered by the Form 144

Shares outstanding 214,336,418 shares RVMD common stock outstanding at the reference date in the notice

Prior 3-month sales 2,157 shares for $336,748.90 Common shares sold by Jeffrey Todd Cislini on June 16, 2026

Restricted Stock Units 614 shares Shares underlying RSUs listed as securities to be sold

Stock options to be exercised 75,280 shares Shares underlying stock options identified as source of securities to be sold

Approximate date of sale 08/21/2026 Date from which sales under this Form 144 may occur on NASDAQ

Key Terms

Rule 144, Restricted Stock Units, Exercise of Stock Options, Aggregate Market Value, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 06/15/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise of Stock Options financial

"Common | 08/21/2026 | Exercise of Stock Options | Issuer"

Aggregate Market Value financial

"Common | Morgan Stanley Smith Barney LLC... | 75894 | 16069416.09"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

NASDAQ market

"214336418 | 08/21/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Revolution Medicines (RVMD)?

It discloses that Jeffrey Todd Cislini intends to sell up to 75,894 shares of RVMD common stock under Rule 144, with an aggregate market value of $16,069,416.09, through Morgan Stanley Smith Barney LLC on or after August 21, 2026 on NASDAQ.

How many Revolution Medicines (RVMD) shares are outstanding in this filing?

The filing states that 214,336,418 shares of Revolution Medicines, Inc. common stock were outstanding as of the reference date used in the Form 144 notice.

What types of RVMD securities is Jeffrey Todd Cislini selling under this Form 144?

The planned sales relate to restricted stock units and shares received upon the exercise of stock options granted by Revolution Medicines, Inc. These underlie the common stock that is the subject of the Rule 144 notice.

Which broker is handling the planned Rule 144 sales for RVMD stock?

The planned sales of Revolution Medicines, Inc. common stock are to be executed through Morgan Stanley Smith Barney LLC – Executive Financial Services, located at 1 New York Plaza in New York.

What RVMD stock sales has Jeffrey Todd Cislini reported in the last three months?

Over the past three months, Jeffrey Todd Cislini reports having sold 2,157 shares of Revolution Medicines, Inc. common stock on June 16, 2026 for an aggregate price of $336,748.90.

When will the RVMD shares covered by this Form 144 be acquired and paid for?

The filer states that the securities to be sold were and will be received upon the exercise of stock options over the next three months and that the dates of acquisition and payment were and will be the dates of exercise/sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 04:34 PM Accepted by SEC EDGAR 08/21/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001969082
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	JEFFREY TODD CISLINI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	75894	16069416.09	214336418	08/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2026	Restricted Stock Units	Issuer			614	06/15/2026	N/A
Common	08/21/2026	Exercise of Stock Options	Issuer			75280	08/21/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEFFREY TODD CISLINI 700 Saginaw Drive Redwood City CA 94063	Common	06/16/2026	2157	336748.90

144: Remarks and Signature

Remarks	The 75,280 securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	08/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeffrey Todd Cislini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)